1024 



SUBJECT INDEX 



Eyes (continued)' 

 vitamin A in, 518 

 xanthophjdlic pigments in, 505 



FAAE (see Fatty acid activating enzyme) 

 FAD (Flavin adenine dinucleotide), in 



fatt}^ acid oxidation, 106 

 Fasting, D : N ratio in, 224, 225 



effect of dietary fat on survival during, 



851-853 

 effect on cholesterol biosj^nthesis, 390 

 on cholesterolemia, 375 

 on fatty acid oxidation, 202, 203 

 on ketogenesis, 178 

 on ketonuria, 139, 140, 194 

 on linolenate stores, 186 

 on lipogenesis, 38, 41, 43 

 on liver lipids, 192, 193 

 on muscle phospholipids, 55 

 on tocopherol storage, 694 

 Fat, body (see also Adipose tiss)ie) 

 as structural element, 836 

 biosynthesis, enzymes involved, 33, 34 

 from carbohydrate, 9 

 hormones involved, 34-37 

 in embryo, 37 



nutritional status and, 37-39 

 carotenoida in, 429, 430, 510, 511, 513 

 effect of tocopherol on deposition, 729, 

 730 

 on rancidity, 737 

 tocopherols in, 691-694 

 unsaturated acids in, 91, 800, 829 

 vitamin A in, 508 

 vitamin D in, 648 

 Fat, dietary, antirachitic effect, 887 



as essential dietary component, 835-898 

 associative dynamic action, 842-845 

 caloric density, 835 

 cholesterol effect on absorption, 419 

 conversion into carbohydrate, 211-233 

 D : N ratio, 223-225 

 effect of epinephrin, 229, 230 



of insulin, 230 

 RQ, 225-228, 231 

 deficiency syndrome, and, 783, 784 

 effect on heating on, 920, 921 



Fat (continued): 



effect on alloxan diabetes, 861-864 

 bacterial action, 865-874 

 biotin, 885 



blood cholesterol, 374, 377 

 Ca utilization, 877, 878 

 carotene absorption, 425, 426 



digestibility, 431 

 cholesterol absorption, 363 



biosynthesis, 392, 393 

 choline oxidase, 242 

 fatty livers, 60 

 galactose utilization, 875 

 growth, 838-845 

 hepatectomy, 860, 861 

 ketosis, 122, 140, 157-159 

 liver lipids, 192, 193 

 longevity, 851-854 

 niacin, 884, 885 

 nitrogen retention, 855, 857 

 pantothenic acid, 881 

 phospholipid synthesis, 59 

 pregnancy, lactation, 846-849 

 pyridoxine, 881-884 

 riboflavin, 880, 881 

 sexual maturity, 845, 846 

 survival in fasting, 851-853 

 thiamine, 864, 865, 878-880 

 thj^rotoxicosis, 857-860 

 vitamin A, 434, 885, 886 

 vitamin B12, 885 

 vitamin D, 652 

 vitamin K, 887 



vitamin requirements, 878-887 

 work capacit}-, 849-851 

 harmful effects, 897, 898 

 intravenous administration, 204-207 

 nutritional value, comparison, 898-920 



effect of level, 920 

 optimum levels, 931-933 

 oxidation, factors affecting, 199-203 

 pathways, 119, 120 

 site, 189-196 

 theories, 71-100 

 subcutaneous administration, 204 

 Fats vs. fatty foods, 837 

 Fatty acid activating enzyme, 106 

 Fatty acid amides, metabolism of, 315-317 



